New York, NY, and Charlotte, NC, October 4, 2020 – Albaron Partners, LP (“Albaron”), a U.S. private equity firm focused on acquiring majority stakes of companies in the specialty healthcare services sector, today announced that it has partnered with a Charlotte-based reproductive endocrinologist to offer advanced fertility treatments under the name of Reproductive Specialists of the Carolinas. The new clinic will be led by Dr. Matrika Johnson, a dual board-certified OB/GYN and reproductive endocrinologist recently recognized as one of Charlotte’s “Top Doctors” by Charlotte Magazine. The investment in Reproductive Specialists of the Carolinas anchors Innovation Fertility, a management services organization specializing in reproductive endocrinology in the Charlotte market. The financial terms of the deal were not disclosed.

Reproductive endocrinology is among the fastest-growing medical specialties. Demand for advanced fertility care will continue to rise as couples are deciding to have children later in life and the prevalence of male infertility, driven by environmental and lifestyle factors, increases. Further trends favoring industry demand are a growing percentage of same-sex couples desiring children and an increasing number of employers offering benefits for IVF and genetic testing services.

“We are thrilled to have Dr. Johnson leading our Charlotte office,” explained Damian Dalla-Longa, Founder and Partner of Albaron. He continued, “Dr. Johnson is incredibly passionate about helping people build families. Her extensive knowledge and her intimate, personalized approach to patient care are completely aligned with our goal of providing the most advanced treatment options and the best patient care. Together, we look forward to leading the way in innovative and patient-centric fertility care in North Carolina.”


Matrika D. Johnson, M.D., is board-certified in Obstetrics and Gynecology as well as Reproductive Endocrinology and Infertility. Since 2020, Dr. Johnson has appeared in Charlotte Magazine’s list of the Top Doctors in Charlotte for reproductive endocrinology and infertility.


Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine some of the premier reproductive endocrinologists of the world with the most experienced laboratory managers and operators in the space, resulting in exceptional medical care and an unparalleled patient experience. For more information, visit:


Albaron is a U.S. private equity firm that invests in and helps accelerate the growth of physician practice groups and microcap healthcare companies. The firm’s goal is to build best-in-class healthcare services platforms that maximize outcomes for all constituents – patients, providers, payors and investors. Albaron’s team is comprised of a seasoned cohort of operating experts and investment professionals who are uniquely qualified to realize significant value through strategic insights, operating support and accretive acquisitions. The team works collaboratively with partnering management teams and leverages its network of industry experts to augment its capabilities. For more information, visit:


This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties, including statements regarding expectations for Reproductive Specialists of the Carolinas following its acquisition by Albaron Partners. If any of these risks or uncertainties materialize, or if any of Reproductive Specialists of the Carolinas’ or Albaron Partners’ assumptions prove incorrect, Reproductive Specialists of the Carolinas’ results could differ materially from the results expressed or implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to Reproductive Specialists of the Carolinas and Albaron Partners as of the date of this communication, and Reproductive Specialists of the Carolinas and Albaron Partners do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.